Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Arthur JR, Nicol F, Beckett GJ
Preservation of the blood brain barrier and cortical neuronal tissue by liraglutide, a long acting glucagon-like-1 analogue, after experimental traumatic brain injury
This stems from immune responses to the peptide structure, as detailed in drug prescribing information
Weight: Early appetite suppression begins around week 3-4
Glucagon-like peptide-1 receptor agonists induce glucose-dependent insulin secretion, beta-cell protection, and other extraglycemic benefits such as weight loss and improvement in markers of cardiovascular risk
The distinction between these two categories carries important regulatory and safety implications
